Natalia Vtyurina, PhD

QA Manager
Natalia Vtyurina, PhD, worked in the ATMP field at Bristol Myers Squibb in the first Europe paperless digital multi-product cell therapy facility in Leiden, the Netherlands. After her postdoc in nanomedicines, she transitioned from academia to the pharmaceutical industry. During the COVID-19 pandemic, she was responsible for release of drug substance vaccines of AstraZeneca to the European market. Natalia is a physicist and holds a PhD in biophysics. She joined ISPE in 2020.